TheraSolve Overview

  • Founded
  • 2009
  • Status
  • Out of Business
  • Employees
  • 2
  • Latest Deal Type
  • Liquidation

TheraSolve General Information


Developer of a technology platform created to promote medication adherence. The company's technology platform targets medication compliance in the form of a patch, called Memopatch, which is a skin patch that supports, motivates and reminds the patients when they need to take medication and improves drug treatment compliance, offering patients to take care of their medications.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Monitoring Equipment
Other Industries
Other Healthcare Technology Systems
Primary Office
  • Agoralaan A bis
  • 3590 Diepenbeek
  • Belgium
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

TheraSolve Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Bankruptcy: Liquidation 20-Apr-2017 00.000 Completed Bankruptcy: Liquidation
2. Later Stage VC (Series A) 22-Jan-2015 00.000 00.000 Completed Generating Revenue
1. Seed Round 18-Aug-2011 Completed Product Development
To view TheraSolve’s complete valuation and funding history, request access »

TheraSolve Executive Team (4)

Name Title Board Seat Contact Info
Stijn Jans Chief Executive Officer
Ivo Abraham Ph.D Chief Scientific Officer & Co-Founder
You’re viewing 2 of 4 executive team members. Get the full list »

TheraSolve Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial